how to track progress on glp-1 medication Progress: Monitoring Weight, HbA1c and Side Effects My GLP-1 Tracker and Journal-

Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor-expressing glutamatergic neurons

Who may be eligible

Du YT, Rayner CK, Jones KL, Talley NJ, Horowitz M (2018) Gastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and management

In adults with overweight or obesity (without diabetes) the semaglutide 2.4 mg dose produced an average weight reduction of about 15% of baseline body weight over ~68 weeks in the STEP 1 trial, a result that surprised many clinicians because it brought pharmacologic outcomes into a range previously associated with surgical interventions

We then applied a biopsychosocial framework to highlight why this effect may be overlooked by GLP-1-treated patients and clinicians

Because of this, the most noticeable weight loss typically happens once you've settled into your full, consistent dose